Haven't read the AFR article but on first impression I don't think this is a good idea for ROC holders. All depends on price though
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025